Risultati della ricerca - Tuomas Mirtti

Validation of fibroblast activation protein and α‐smooth muscle actin as prognostic biomarkers in prostate cancer through AI ‐assisted image analysis of dual‐marker IHC di Jenni Säilä, Timo‐Pekka Lehto, Antti Rannikko, Olli Kallioniemi, Tuomas Mirtti, Teijo Pellinen

Testo

Altered Glycosylation of PSA in Prostate Cancer Tissue di Hannu Koistinen, Ruusu‐Maaria Merivirta, Timo‐Pekka Lehto, Anna Lempiäinen, Andrew Erickson, Ulf‐Håkan Stenman, Antti Rannikko, Tuomas Mirtti

Testo

Comparable recurrence risk for MRI ‐detected Gleason Grade Group (GG) 2 and systematic biopsy‐detected GG1 prostate cancer di Abderrahim‐Oussama Batouche, Eugen Czeizler, Timo‐Pekka Lehto, Andrew Erickson, Tolou Shadbahr, Teemu D. Laajala, Joona Pohjonen, Tuomas Mirtti, Antti S. Rannikko

Testo

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy di Piotr Bialas, Tamae Kobayashi, Rebecka Hellsten, Agnieszka Krzyzanowska, Margareta Persson, Felicia Marginean, Dominique Trudel, Isla P. Garraway, Bruce J. Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice Knudsen, Angelo M. De Marzo, Anders Bjartell

Testo

Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens di Brennan T Flannery, Howard M Sandler, Priti Lal, Michael D Feldman, Juan C Santa‐Rosario, Tilak Pathak, Tuomas Mirtti, Xavier Farre, Rohann Correa, Susan Chafe, Amit Shah, Jason A Efstathiou, Karen Hoffman, Mark A Hallman, Michael Straza, Richard Jordan, Stephanie L Pugh, Felix Feng, Anant Madabhushi

Testo